| http://www.w3.org/ns/prov#value | - Because these compounds do not interact with classical ERs, it is also likely that they will not trigger the unwanted side effects of chronic hormone therapy in postmenopausal women, such as increased risk of thrombosis, stroke, cardiovascular events and breast cancer, associated with the activation of classical ERs [3], [4].It is well established that E2 pretreatment for days to weeks before brai
|
